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Abstract
Background: The physiological function of p38α, which is an isoform of p38 MAPK, has been investigated
previously in several studies using pharmacological inhibitors. However, the results regarding whether p38α
promotes or inhibits nerve regeneration in vivo have been controversial.
Methods: We generated novel p38α mutant mice (sem mice) with a point mutation in the region encoding the
p38α substrate-docking-site, which serves as a limited loss-of-function model of p38α. In the present study, we
utilized sem mice and wild-type littermates (wt mice) to investigate the physiological role of p38α in nerve
regeneration following crush injuries.
Results: At four weeks after crush injury, the average axon diameter and the average axon area in sem mice were
significantly smaller than those in wt mice. The average myelin sheath thickness in sem mice was reduced
compared to wt mice, but no significant difference was observed in the G-ratio between the two groups. The
sciatic functional index value demonstrated that functional nerve recovery in sem mice following crush injury was
delayed, which is consistent with the histological findings. To investigate the underlying mechanisms of these
findings, we examined inflammatory responses of the sciatic nerve by immunohistochemistry and western blotting.
At an early phase following crush injury, sem mice showed remarkably lower expression of inflammatory cytokines,
such as TNF-α and IL-1β, than wt mice. The expression of Caspase-3 and Tenascin-C were also lower in sem mice.
Conversely, at a late phase of the response, sem mice showed considerably higher expression of TNF-α and of IL-1β
with lower expression of S-100 than wt mice.
Conclusions: This is the first study of the physiological role of p38 MAPK in nerve regeneration that does not rely
on the use of pharmacological inhibitors. Our results indicate that p38α insufficiency may cause an inflammatory
disorder, resulting in a delay of histological and functional nerve recovery following crush injury. We conclude that
p38 MAPK has an important physiological role in nerve regeneration and may be important for controlling both
initiation of inflammation and recovery from nerve injury.
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Background
It is well known that the peripheral nervous system is
remarkable in its ability to regenerate after injury. In the
transected or crushed peripheral nerve, the distal seg-
ment undergoes Wallerian degeneration, which is essen-
tial for the subsequent processes of nerve regeneration
[1]. Therefore, understanding the molecular mechanisms
between nerve degeneration and regeneration holds the
key to further advances in the clinical management of
such injuries. In the event of nerve regeneration, cytokines
have been considered to be critical components, since
these are important mediators of communication between
various types of cells. Furthermore, it has been reported
that expression of cytokines, including pro- and anti-
inflammatory cytokines, are controlled in a highly ordered
fashion during Wallerian degeneration and subsequent
regeneration in the peripheral nerve system [2,3]. Of these
* Correspondence: drkato@saitama-med.ac.jp
1Department of Orthopaedic Surgery, Saitama Medical University, Saitama,
Japan
2Department of Orthopaedic Surgery, Saitama Medical Center, Saitama
Medical University, 1981 Kamoda, Kawagoe City, Saitama 350-8550, Japan
Full list of author information is available at the end of the article
JOURNAL OF 
NEUROINFLAMMATION
© 2013 Kato et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Kato et al. Journal of Neuroinflammation 2013, 10:1
http://www.jneuroinflammation.com/content/10/1/1
pro-inflammatory cytokines, TNF-α is upregulated early
and transiently at the site of nerve injury and is considered
to play a crucial role in the process of Wallerian degene-
ration as an initiator of local inflammatory responses [2,4].
However, the complex signaling pathways controlling these
events remain unknown. Further understanding of the cell
and molecular program controlling the expression of in-
flammatory cytokines following nerve injuries is important
in order to devise ways to promote nerve regeneration.
Mitogen-activated protein kinase (MAPK) cascades
are highly conserved signal transduction pathways coup-
ling different extracellular signals to a variety of intrace-
llular responses [5]. The signaling pathway is similar for
all the members of the MAPK family and is typically
composed of a highly conserved MAPK module com-
prising three kinases, namely MAPK kinase kinase
(MKKK), MAPK kinase (MKK) and MAPK. The p38
MAPK is a member of this MAPK family of serine-
threonine kinases, which is specifically activated by
phosphorylation under conditions of hypoxia, stress, and
exposure to inflammatory cytokines [6]. Activated p38
MAPK subsequently phosphorylates its substrates, in-
cluding protein kinases such as MAPKAP kinase-2 and
several transcription factors including MEF2, CHOP, and
ATF-2, leading to the induction of cell proliferation and/
or apoptosis [7]. In this pathway, dephosphorylation of
either Thr180 or Tyr182 is sufficient to inactivate p38
MAPK, and this can be mediated by tyrosine-specific
MAPK phosphatases. The MAPK cascade can also in-
duce phosphatase gene transcription, providing a nega-
tive feedback for MAPK activation.
It has been reported that p38 MAPK has four isoforms,
p38α, p38β, p38γ, and p38δ, which share 60% to 70%
amino acid sequence identity. Although these isoforms
have overlapping substrate specificity, some substrates
appear to be preferentially phosphorylated by one or more
isoforms [8]. Of these isoforms, p38α is expressed ubiqui-
tously and has been proposed to regulate many cellular
processes. In the nervous system, it has been reported that
p38α plays critical roles in the differentiation and/or sur-
vival of neurons, regulating neural plasticity and inflamma-
tory responses. Considering that inflammatory responses
induced by nerve injury are indispensable for subsequent
nerve regeneration, further investigation of the p38α
signaling pathway may be a key to understanding the
mechanisms regulating nerve regeneration.
There are a large number of reports regarding p38α
function in cultured cells. However, very little is known
about the physiological role of this MAPK in vivo, since
p38α is essential for mammalian embryonic develop-
ment and loss of p38α causes embryonic death [9,10]. In
vivo studies to investigate p38 MAPK function have
usually been undertaken using pharmacological inhibi-
tors, such as SB 203580, which targets both p38α and
p38β [11]. However, the physiological function of p38
MAPK in vivo remains controversial. Temporin et al.
reported that SB 203580 reduced axonal length in a
neurite outgrowth assay. In that study, the activation of
RhoA appeared to be responsible for this effect, since
the addition of SB 203580 increased RhoA activity to
2.1-fold compared with control group [12]. On the other
hand, Myers et al. found that SD-169, a novel oral in-
hibitor of p38 MAPK, increased the rate of nerve fiber
regeneration following peripheral nerve crush injury
[13]. The reasons for these conflicting results are not en-
tirely clear, however, we surmise that the specificity of
these chemical inhibitors, critically depending on their
concentration, might be a contributing factor. Godl
et al. studied the selectivity of SB 203580, widely used as
a p38 MAPK inhibitor, using a proteomics approach and
reported that RICK (Rip-like interacting caspase-like
apoptosis-regulatory protein kinase/RIP2/CARDIAK)
was even more potently inhibited by SB 203580 than
p38α. Since RIP2/RICK/CARDIAK is a member of the
receptor interacting protein kinase (RIP) family and pro-
motes NF-κB activation as well as activation of the
MAPKs JNK, ERK1/2 and p38 MAPK, these authors
commented that incorrect conclusions might have been
drawn from numerous experiments, in which SB 203580
was used as a ‘specific’ p38 inhibitor [14]. Thus, to
understand the precise physiological functions of p38α
in vivo, more specific methods than pharmacological in-
hibition are required.
It has been reported that docking interactions of MAPKs
via docking domains are important in regulating both the
activation and inactivation of these kinases, and mutation
of this docking domain in p38α/p38β disrupted the p38
docking interaction, resulting in dysfunction of p38α and
p38β [15]. In this domain, two aspartate acids are essential
for docking and the so-called sevenmaker mutant, in which
one of these two aspartate acids is changed, showed mar-
kedly decreased kinase activity on MAPK phosphatase-1
in vitro [16,17].
Recently, we generated novel p38α mutant mice with a
point mutation in the p38α substrate-docking-site. Using
the Cre/lox-conditional mutation system, we converted
aspartate acid at position 316 in exon 11 of p38α to as-
paragine. As a result, these mutant mice, termed sem
(sevenmaker type Mapk14) mice, possess a knock-in muta-
tion in p38 MAPK (D316N) [18]. In the present study, we
utilized these sem mice and wild-type littermates (wt mice)
to investigate the physiological role of p38α during nerve
regeneration following crush injury.
Materials and methods
Animals
Sem C57BL/6N mice were bred with wt C57BL/6N mice.
Approximately half of the resulting offspring carried the
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mutant p38α gene, as confirmed by polymerase chain re-
action (PCR) genotyping with primers specific for the mu-
tant p38α gene, 50-TAG ATA CAG AGC CAT CAG ACC
ACC A-30 (sense primer) and 50-TGA ATG GTG TAG
CATAGG CTG GA-30 (antisense primer), applied to total
cellular DNA isolated from tail snip tissue. Adult, male,
sem mice with heterozygous mutant p38α gene (p38+/−)
(12 to 16 weeks old, weighing 13 to 22 g) and wt litter-
mates (p38+/+) (12 to 16 weeks old, weighing 17 to 27 g)
were housed on a 12-hour light/dark cycle with ad libitum
access to food and water. Body weights of both sem mice
and wt mice were measured weekly. Both genotypes con-
tinued to steadily increase their weight but wt mice were
measurably larger than that of sem mice throughout the
experimental periods. This study was carried out in
accordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals published by the
National Institutes of Health, and the protocol was
approved by the Committee on the Ethics of Animal
Experiments of Saitama Medical University (approved
number 673).
Nerve crush injury model
All surgical procedures were carried out under sodium
pentobarbital anesthesia (30 to 50 mg/kg, injected intra-
peritoneally). The left sciatic nerve was exposed through a
gluteal muscle-splitting approach. A crush injury was then
applied to the nerve at 5 mm distal to the sciatic notch
using a brain aneurysm clip (Sugita clip; Mizuho Ikakogyo,
Tokyo, Japan). The clip was left in place for three minutes
with a holding force of approximately 250 g.
Twenty mice were divided into two equal groups:
p38α mutant mice (sem mice; n = 10) and wild-type li-
ttermate mice (wt mice; n = 10). These mice were
assessed by immunohistochemistry (see below) for the
expression of TNF-α, IL-1β, Caspase-3 and Tenascin-C
at three days after crush injury. Functional evaluation of
nerve recovery and histological assessment including the
expression of TNF-α, IL-1β and of S-100 at four weeks
after crush injury were investigated through the use of
another cohort of mice (n = 10 per group).
Histological studies
At four weeks after crush injury, specimens of the crushed
sciatic nerve were taken at 5 mm distal to the injury site
and fixed with PBS containing 1.85% paraformaldehyde
(PFA, pH 7.4) and 0.25% glutaraldehyde, as described pre-
viously [19,20]. As controls, tissue specimens were also
taken from the contralateral uninjured sciatic nerve. All
specimens were post-fixed with 2% osmium tetroxide,
dehydrated in serially increasing concentrations of alcohol
and ether, and then embedded in Epon resin (Quetol 512;
Nisshin EM, Tokyo, Japan). Each section (1 μm in thick-
ness) was stained with toluidine blue and examined under
a light microscope. For the morphometric study of the
sciatic nerve, three consecutive sections of one nerve were
chosen, and a set of three non-overlapping fields was eva-
luated using random sampling from each section. The
evaluated area covered approximately two-thirds of the
total area of one nerve section. These were analyzed using
ImageJ software (ver. 1.38, NIH, http://rsbweb.nih.gov/ij/).
Morphometric measurements of the sciatic nerve
included: 1) axon (fiber without myelin sheath) diameter
distribution; 2) average axon diameter (μm); 3) average
axon area (μm2); 4) average axon number (N); 5) average
axon density (N/mm2); 6) average G-ratio (quotient axon
diameter / fiber diameter, a measure of the degree of mye-
lination); and 7) average myelin sheath thickness (μm).
Functional studies
All animals underwent walking track analysis, as described
previously [21]. Paw prints were recorded by moistening
the hind paws of each animal with blue ink and having
them walk unassisted along a 6 × 44 cm corridor under-
lain with white construction paper. All tracks were ana-
lyzed in a blinded fashion before crush injury (0 week),
and 1, 2, 3, 4 weeks following crush injury. Prints for
measurement were chosen for clarity and consistency at a
point when the mouse was walking at a moderate pace. If
necessary, the animals were walked multiple times in
order to obtain measurable prints. The tracks were evalua-
ted for two different parameters: toe spread (TS), being
the distance between the first and fifth toes, and print
length (PL), the distance between the third toe and the
hind pad. Measurements of all the parameters were made
for the right (control) and the left (experimental) paw
prints, and the sciatic functional index (SFI) was calcu-
lated according to the formula: SFI = 118.9 (ETS - NTS) /
NTS - 51.2 (EPL - NPL) NPL - 7.5, where ETS is experi-
mental TS, NTS is control TS, EPL is experimental PL
and NPL is control PL.
The SFI value characterizes crucial aspects of locomo-
tion activities, involving recovery of hind limb sensory and
motor function. It varies from 0 to −100, with 0 corres-
ponding to normal function and −100 corresponding to
complete dysfunction.
Immunohistochemical studies
Immunohistochemical examination of the nerve was
performed at both three days and four weeks after crush
injury. Specimens were taken from the sciatic nerve at 5
mm distal to the crush lesion, and fixed for three hours
followed by cryoprotection in 30% sucrose for six hours.
They were subsequently embedded in optimal cutting
temperature (OCT) compound and were frozen at −80°C.
Serial sagittal sections of 20 μm were cut on a cryostat
and mounted on silane-coated slides. After washing
with PBS, they were treated with 0.3% H2O2 in 90%
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methanol for 30 minutes to inactivate endogenous per-
oxidase. The sections were rinsed with PBS for 30 min-
utes and treated with 10% normal goat blocking serum
in PBS for one hour at room temperature to block non-
specific protein binding. Sections were then incubated
overnight at room temperature in a humidified chamber
with antibody. Polyclonal rabbit anti TNF-α and mono-
clonal mouse anti S-100 antibodies were purchased from
Abcam (Cambridge, MA, USA). Polyclonal rabbit anti
IL-1β antibody was purchased from Santa Cruz Biotech
(Santa Cruz, CA, USA). Polyclonal rabbit anti Caspase-3
antibody and rabbit anti Tenascin-C antibody were pur-
chased from Lifespan Bioscience (Seattle, WA, USA).
The secondary antibody and detection systems were
Vectastain ABC kit and DAB peroxidase substrate kit
(Vector Lab., Burlingame, CA, USA). Furthermore, the
sections for S-100 immunohistochemistry were counter-
stained with hematoxylin to evaluate cellularity.
For the immunohistochemical study of the sciatic nerve,
specimens were analyzed at 400x magnification and a
density threshold was set for each section to identify the
immunopositive area using ImageJ software (ver. 1.38,
NIH). The ratio of the immunopositive area to the total
area of the field was calculated as the immunopositive rate
(%). For the evaluation of cellularity, the number of cells
per microscopic field was counted and expressed as the
cell density (N/mm2). These analyses were performed
using three non-overlapping microscopic fields, which
were randomly selected from each section. The evaluated
area covered approximately two-thirds of the total area of
one nerve section. All histological and immunohistoche-
mical evaluations were performed by an investigator who
was blinded to the genotype and injury status of the mice.
Western blot analysis
Western Blotting of sciatic nerve protein was performed
at four weeks after crush injury. Specimens were taken
from the sciatic nerve at 5 mm distal to the crush lesion
and from the contralateral uninjured sciatic nerve. These
specimens were homogenized in lysis buffer (20 mM
Hepes, pH 7.4, 2 mM EGTA, 50 mM β-glyceropho-
sphate, 0.1% Triton X-100, 10% glycerol, 1 mM dithio-
threitol, 1 μg/ml leupeptin, 5 μg/ml aprotinin, 1 mM
phenylmethylsulfonyl fluoride, 1 mM sodium orthovana-
date). After centrifugation at 10,000 × g for 15 minutes
at 4°C, the supernatants were electrophoresed on a 10%
SDS-polyacrylamide gel and blotted onto polyvinylidene
difluoride membranes. Immunoblot detection was per-
formed with the corresponding polyclonal rabbit anti
TNF-α antibody (Abcam) and polyclonal rabbit anti IL-
1β antibody (Santa Cruz Biotech) using a ECL detection
kit (Amersham Pharmacia Biotech, Buckinghamshire,
UK). The membranes were then stripped and reprobed
with polyclonal rabbit anti-β-actin antibody (Santa Cruz
Biotech), which was used as control for protein loading.
Band intensities at each time point (n = 3 samples per
group) were analyzed and quantified as relative density
against control.
Statistical analysis
All values of morphometric parameters from histological
studies, functional studies, immunohistochemical studies
and western blot analysis were expressed as means ± S.
D. All statistical analyses were assessed using Student’s t




Results from previous studies using pharmacological
inhibitors to investigate whether p38α promotes or inhi-
bits nerve regeneration in vivo have been controversial.
Therefore, we first evaluated nerve regeneration after
crush injury. Baseline differences in nerve development
due to the p38α mutation were determined by taking
specimens from the contralateral uninjured sciatic nerve
of both sem and wt mice. Both groups showed a dense
axon population with many large-diameter axons with a
thick myelin sheath (Figure 1a). Morphometric para-
meters of the contralateral sciatic nerve were not diffe-
rent between the two groups (Table 1). Four weeks
following crush injury, many small-diameter axons with
a thin myelin sheath were observed in both groups, al-
though large-diameter axons were coexisting in wt mice.
Axon diameter distribution showed increased proportion
of small-diameter axons (<1 μm), which were similar bet
ween the two groups (Figure 1b), Morphometric para-
meters of the crushed sciatic nerve showed that the
average axon diameter and area in sem mice were sig-
nificantly smaller than that in wt mice (P < 0.05, P < 0.01,
respectively). The average myelin sheath thickness in sem
mice was also significantly reduced after crush injury com-
pared to wt mice (P < 0.05), however, no significant dif-
ferences were observed in the axon number, density and
G-ratio between the two groups (Table 1). These findings
suggest that inhibition of p38α influences nerve rege-
neration rather than neural development. Therefore, we
consider that these sem mice are a suitable model, in
which to investigate the physiological role of p38 MAPK
in nerve regeneration.
Functional studies
To evaluate total nerve regeneration in vivo, we applied
SFI, which is an index of functional nerve recovery. Until
two weeks after crush injury, SFI values showed no signifi-
cant differences between wt and sem mice. However, the
SFI value in sem mice was significantly lower than that
in wt mice at three and four weeks after crush (P < 0.01)
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(Figure 2). This result demonstrates that functional nerve
recovery of sem mice following crush injury was delayed,
which is consistent with the histological findings.
Immunohistochemical studies
Activation of p38 MAPK, and proinflammatory cyto-
kines such as TNF-α and IL-1β, is considered to be
regulated by interactions between these cytokines. It has
been reported that systemic administration of p38 inhi-
bitors results in reduced synthesis of TNF-α and IL-1β
[22], and that p38 MAPK is activated by TNF-α [6],
leading to induction of cell proliferation and/or apop-
tosis [7]. TNF-α is also known to activate p38 MAPK in
Schwann cells, by upregulating the expression of IL-1β
and increasing nerve growth factor (NGF) secretion
[13,23]. The relationship between TNF-α and p38
MAPK is one of positive feedback in that TNF-α phos-
phorylates p38 MAPK, resulting in upregulation of
TNF-α biosynthesis in the same cell type [13]. To inves-
tigate the effect of p38 MAPK on cytokine expression
Figure 1 Histological assessment of nerve regeneration at four weeks after crush injury. At four weeks after crush injury, specimens of the
crushed sciatic nerve were taken at 5 mm distal to the injury site from both sem (p38+/−) and wt (p38+/+) mice. As controls, tissue specimens
were also taken from the contralateral uninjured sciatic nerve. (a) A 1 μm slice section was stained with toluidine blue and examined under a
light microscope. Scale bar indicates 50 μm. (b) Axon diameter distribution of the sciatic nerve was evaluated using a set of three non-
overlapping microscopic fields.
Table 1 Morphometric parameters of the nerve at four weeks after crush injury
Crush side Contralateral side
p38+/+ p38+/− P p38+/+ p38+/− P
Axon diameter (μm2) 1.52±0.06 1.37±0.04* <0.05 3.87±1.37 3.75±1.64 N.S.
Axon area (μm2) 5.24±0.36 3.15±0.15** <0.01 10.21±2.34 9.93±2.94 N.S.
Axon number (N) 2850±550 2700±650 N.S. 5800±300 5650±250 N.S.
Axon density (N/mm2) 11500±4100 10150±4650 N.S. 22450±3050 21050±2800 N.S.
G-ratio 0.86±0.05 0.87±0.04 N.S. 0.74±0.03 0.75±0.05 N.S.
Myelin sheath thickness (μm) 0.18±0.06 0.15±0.13* <0.05 0.98±0.29 0.96±0.33 N.S.
N.S., not significant.
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after crush injury, we determined the expression of TNF-α
and IL-1β in the sciatic nerve using immunohistochemistry.
In the early phase (three days after injury), strong
TNF-α immunoreactive (−ir) lesions spread over the
entire area of the nerve bundle in wt mice, however sem
mice showed fewer stained TNF-α-ir lesions. The TNF-α
positive rate in sem mice was 1.3 ± 0.8%, which is signifi-
cantly lower (P < 0.01) than that of wt mice (5.8 ± 1.7%)
(Figure 3a). The number of intense IL-1β-ir lesions was
also lower in the sciatic nerves taken from sem mice com-
pared with that from wt mice. The IL-1β positive rate
of sem and wt mice was 2.2 ± 0.9% and 6.3 ± 1.5%, res-
pectively, which also represents a significant difference
(P < 0.01) (Figure 3b). In the contralateral uninjured scia-
tic nerve, TNF-α-ir lesions and IL-1β-ir lesions were com-
pletely absent endoneurially in both sem and wt mice
(data not shown).
We further investigated the process of Wallerian
degeneration, which is known to be an apoptotic
phenomenon of peripheral nerves following traumatic
injury and is essential for subsequent nerve regeneration.
To investigate this process in the early phase after injury,
we observed the expression of Caspase-3, which was
reported to be expressed in Schwann cells after nerve
injury [24] and to be activated in the effector phase of
the apoptotic process leading to cell death within a few
hours [25]. It is considered that the expression of
Caspase-3 represents a reliable tool for the identification
of Wallerian degeneration. At three days after nerve
injury, intense Caspase-3-ir lesions were found in the
entire area of the endoneurium in the sciatic nerves in
wt mice, but were rarely found in sem mice. When
quantified, the Caspase-3 positive rates in sem and wt
mice were 0.8 ± 0.5% and 2.1 ± 0.7%, respectively, repre-
senting a significantly lower positive rate in sem mice
(P < 0.05) (Figure 4a). By contrast, the contralateral nerve
specimens taken from both sem mice and wt mice showed
no expression of Caspase-3 (data not shown).
Next, we investigated the expression of Tenascin-C, an
oligomeric glycoprotein of the extracellular matrix,
which is diffusely expressed during neurogenesis in the
peripheral nervous system [26]. It is also reported that
the expression of Tenascin-C occurs within two days
after removal of epiperineurium as part of the regenera-
tive response [27] and its upregulation is an important
prerequisite for axonal regrowth after peripheral nerve
injury [28]. At three days after nerve injury, intense
Tenascin-C-ir lesions were found in the entire area of
the endoneurium in the sciatic nerves in wt mice but
fewer lesions were observed in sem mice. The Tenascin-
C positive rates in sem and wt mice were 1.2 ± 0.9% and
6.3 ± 2.2%, respectively, which was significantly different
(P < 0.01) (Figure 4b). In the contralateral nerve speci-
mens, the expression of Tenascin-C was observed only
in the perineurium (data not shown). Together, these
results indicate that p38 MAPK might cause TNF-α and
IL-1β upregulation in the crush injured nerve lesion and
play a positive role for axonal regrowth following Wallerian
degeneration at early phase after injury.
We next investigated immunohistochemically the ex-
pression of cytokines during the late response phase
(four weeks after injury). It has been shown that the
expression of both TNF-α and IL-1β is downregulated at
this phase. At four weeks after crush injury, TNF-α-ir
lesions could be still observed in sem mice but not in wt
mice. The positive rate in sem mice was significantly
higher (0.9 ± 0.4%) than that of wt mice (0.3 ± 0.2%)
(P < 0.05) (Figure 5a). IL-1β expression in sem mice
(0.8 ± 0.6%) was also higher than that in wt mice (0.6 ±
0.4%), but this did not reach significance (Figure 5b). In
addition, Schwann cells were stained using an anti S-100
antibody, a marker of mature Schwann cells, after which
Figure 2 Functional nerve regeneration after crush injury. The sciatic functional index (SFI) was calculated before crush injury (0 week), and
1, 2, 3, 4 weeks following crush injury using two different parameters: toe spread (TS) and print length (PL). Asterisks indicate significant time
point-specific differences (**P <0.01).
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these specimens were counterstained to evaluate cellula-
rity. S-100-ir areas were observed diffusely around axons
and their intensity in wt mice was stronger than that in
sem mice (Figure 6a). In addition, the cellularity in sem
mice (5846.4 ± 482.5) was significantly higher than that
in wt mice (4647.6 ± 598.1) (Figure 6b, P < 0.01). These
results indicate that nerve regeneration was retarded in
sem mice compared with that in wt mice.
Western blot analysis
Analysis of protein levels by western blotting revealed
that, in both groups, only low levels of TNF-α and IL-1β
were present in contralateral sciatic nerves (data not
shown). However, the expression levels of both cytokines
in wt mice was markedly increased at three days follo-
wing crush injury (approximately three-fold over control
values). The increase was transient and both expression
levels returned to control values at four weeks after
crush injury. In contrast to the changes observed in wt
mice, there was no observable change in the expression
of either cytokine in sem mice at three days after crush
injury. However, consistent with the immunohistoche-
mical findings, increases in the levels of TNF-α were
observed at four weeks after crush (approximately two-
Figure 3 The expression of TNF-α and IL-1β at three days after crush injury. At three days after crush injury, specimens of the crushed
sciatic nerve were taken at 5 mm distal to the injury site from both sem (p38+/−) and wt (p38+/+) mice. Each section was processed for
immunostaining using anti TNF-α antibody, and anti-IL-1β antibody. Scale bar indicates 50 μm. The ratio of the immunopositive area of (a) TNF-α
and (b) IL-1β to the total area of the field was calculated as the immunopositive rate, respectively. Asterisks indicate significant difference
between genotypes (**P <0.01).
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fold over control values) in sem mice. IL-1β levels in
sem mice were also slightly higher than those in wt
mice. Between sem and wt mice, statistically significant
differences were observed in the expression of TNF-α
and IL-1β at three days after crush, and of TNF-α at
four weeks after crush (P < 0.05, P < 0.01, and P < 0.01,
respectively) (Figure 7).
Discussion
Peripheral nerves are known to have a considerable capa
city for regeneration after injury, a process regulated by
several inflammatory cytokines expressed within the
injured nerve. An understanding of the function of in-
flammatory cytokines and cytokine-regulatory proteins
during nerve regeneration offers the potential for broad-
reaching therapeutic intervention. Therefore, this regu-
lated complex signaling cascade has been an area of in-
tense investigation.
The p38 MAPK is one of the most important kinases
in regulating the inflammatory signaling cascade, so that
many different p38 MAPK inhibitors, all of which are
competitive with ATP, have been used to investigate the
physiological role of p38 MAPK in vitro. Of these,
SB203580, the pyridinyl imidazole compound, has been
widely used as a specific inhibitor of p38 MAPK. How-
ever, it was recently revealed that this inhibitor affects se-
veral unrelated kinases, therefore, incorrect conclusions
might have been drawn from numerous experiments in
Figure 4 The expression of Caspase-3 and Tenascin-C at 3 days after crush injury. At three days after crush injury, specimens from both
sem (p38+/−) and wt (p38+/+) mice were processed for immunostaining using anti Caspase-3 antibody, and anti Tenascin-C antibody. Scale bar
indicates 50 μm. The ratio of the immunopositive area of (a) Caspase-3 and (b) Tenascin-C to the total area of the field was calculated as the
immunopositive rate, respectively. Asterisks indicate significant difference between genotypes (*P <0.05, **P <0.01).
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which SB 203580 was used as a ‘specific’ p38 inhibi-
tor [14]. Thus, it is of importance to explore ‘specific’
methods to block the phosphorylation of specific sub-
strates mediated by p38 MAPK. This is the first report
showing the physiological role of p38 MAPK in vivo
by specifically blocking its docking-domain. Recently,
we confirmed by immuno-precipitation that p38 MAPK
derived from sem mice maintains interactions with
transcription factors, including activating transcription
factor 2 (ATF2) but not with protein kinases such as
mitogen-activated protein kinase-activated protein kinase
2 (MAPKAPK2) [18]. This finding indicates that sem mice
can be used to investigate limited loss-of-function of p38
MAPK. Using these mutant mice, we have confirmed that
p38 MAPK insufficiency delays nerve regeneration follow-
ing crush injury, both histologically and functionally.
George et al. [29] reported that TNF-α was increased
in the injured mouse sciatic nerve on day 1 and returned
to the control level on day 7 after crush injury. There
are also several reports showing that endoneurial TNF
protein expression peaked early and transiently in mouse
sciatic nerves at the site of lesion [30,31]. It has been
reported that TNF-α functioned as a primary mediator
to initiate the cascade of nerve degenerative events, in-
ducing many changes in Schwann cells and neuron gene
expression [2,3]. Consequently, TNF-α is recognized as a
biomarker of Wallerian degeneration in the injured
nerve. Direct injection of TNF-α into uninjured nerves
Figure 5 The expression of TNF-α and IL-1β at four weeks after crush injury. At four weeks after crush injury, specimens from both sem
(p38+/−) and wt (p38+/+) mice were processed in the same way as shown in Figure 4. Scale bar indicates 50 μm. The ratio of the
immunopositive area of (a) TNF-α and (b) IL-1β to the total area of the field was calculated as the immunopositive rate, respectively. Asterisks
indicate significant difference between genotypes (*P <0.05) and N.S. indicates no significant difference.
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Figure 6 The expression of S-100 and cellularity at four weeks after crush injury. (a) At four weeks after crush injury, specimens from both
sem (p38+/−) and wt (p38+/+) mice were processed for immunostaining using anti S-100 antibody. Scale bar indicates 50 μm. (b) Cellularity was
evaluated by counting the number of cells per microscopic field and expressed as the cell density (N/mm2). Asterisks indicate significant
difference between genotypes (**P <0.01).
Figure 7 Western blot analysis. Protein lysates extracted from sciatic nerves from both wt (p38+/+) and sem (p38+/−) mice were examined by
western blotting for TNF-α and IL-1β expression at three days and four weeks following crush injury. Expression at each time point (n = 3 samples per
group) were analyzed and quantified as relative density against control.
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causes demyelination, macrophage infiltration, and pain,
mimicking changes observed in injury [3,32].
On the other hand, IL-1β is known to have several bene-
ficial effects on the nervous system, promoting Schwann
cell proliferation [33], neuron survival [34,35], synthesis of
nerve growth factor (NGF) [36], and oligodendrocyte
remyelination [37]. Furthermore, it has also been reported
that IL-1β overcomes neurite outgrowth inhibition by
deactivating the small GTPase RhoA, which results in
promoting nerve regeneration. Temporin et al. [12]
reported that expression of IL-1β was increased one day
after nerve injury, and that this increase in expression per-
sisted for 7 days. Taken together, it is considered that the
expression of both TNF-α and IL-1β is indispensable for
the early phase of nerve regeneration after injury.
In this study, the expression of TNF-α and IL-1β in p38
MAPK-insufficient sem mice was significantly lower than
that in wt mice at three days after crush injury. This result
implies that p38 MAPK functions as an upstream signal
of TNF-α and IL-1β in vivo, and also suggests that
reduced expression of these cytokines may be an obstacle
to fulfill Wallerian degeneration and subsequent regene-
ration in the early phase after injury. It has been reported
that adult dorsal root ganglion neurons in culture do not
extend neurites in cryosections of normal sciatic nerve,
but do on cryosections of pre-degenerated nerves [38].
Wallerian degeneration, which is induced by TNF-α, is
required for nerve regeneration. Therefore, this might be
one of the mechanisms by which regeneration is retarded
in the mutant mice. However, intriguingly, we observed
elevated TNF-α expression at four weeks after crush in-
jury in sem mice. It is well known that the activation of
p38 MAPK occurs transiently followed by its dephospho-
rylation. However, in sem mice, the expression of phos-
phorylated p38 MAPK is prolonged due to an inability to
bind its substrates, such as MAPKAPK2. This impairment
of p38 MAPK autorepression might be one of the reasons
for the elevation of TNF-α at four weeks after crush
injury. We consider that this prolonged expression of
TNF-α might be deleterious for successful nerve regener-
ation. Agents that target TNF-α and IL-1β have received
attention as potential therapeutics for nerve injury, due to
their inflammatory effect. However, whether clinical appli-
cation of neutralizing antibody and/or receptor antagonist
of these would be effective has not reached consensus. It
is likely that TNF-α and IL-1β play different roles at diffe-
rent phases of nerve regeneration. Therefore, further stu-
dies are required to elucidate the molecular mechanisms
regulating inflammation in the nervous system.
Previously, it has been reported that the expression of
Caspase-3 is upregulated in the endoneurium at ten days
after nerve transection [39], and that Tenascin-C demon-
strates peak expression during the first two weeks after
nerve injury and becomes downregulated subsequently
when axons regenerate [40,41]. Our results in wt mice are
consistent with these previous data, and indicate that ele-
vation of Caspase-3 followed by expression of Tenascin-C
are important early responses in injured peripheral nerves.
In this study, expression both Caspase-3 and Tenascin-C
was significantly lower in sem mice than that in wt mice.
This result supports the idea that the inhibition of p38
MAPK retarded Wallerian degeneration and subsequent
axonal regeneration after nerve injury.
We also confirmed that the expression of S-100 was
inhibited in sem mice and the cellularity in sem mice was
higher than that in wt mice at four weeks after crush in-
jury. This decreased expression of S-100 in the late phase
after injury was consistent with previous findings [42] and
the increase in cellularity is not surprising, given the
attendant changes in the progressing degenerating-
regenerating nerve [43]. We consider these changes to
also be secondary to the insufficiency of p38 MAPK and
of TNF-α and IL-1β in sem mice.
In this report, we describe the specific inhibition of p38
MAPK in vivo without the use of chemical inhibitors, and
we have confirmed for the first time that the inhibition of
p38 MAPK delays nerve regeneration following crush
injury, both histologically and functionally. Our findings
suggest that molecular targets to regulate the repair of
damaged peripheral nerves might exist in the p38 MAPK
signaling pathway. We did not evaluate either the intrinsic
responses of the neurons in dorsal root ganglia or changes
of non-myelinated axons in sciatic nerves in this study.
However, our current findings support the approach of
specific modulation of inflammatory responses in the
treatment of peripheral nerve injury. Further studies are
now required to clarify the physiological role of the p38
MAPK signaling pathway for nerve regeneration.
Conclusions
This is the first study of the physiological role of p38
MAPK in nerve regeneration that does not rely on the
use of pharmacological inhibitors. Our results indicate
that p38α insufficiency may cause an inflammatory
process disorder, resulting in a delay of histological and
functional nerve recovery following crush injury. We
conclude that p38 MAPK has an important physiological
role in nerve regeneration and may be important for
controlling both initiation of inflammation and recovery
from nerve injury.
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